Home › NDC Lookup › RxCUI directory › RxCUI 582808

Carbamide peroxide 100 MG/ML Mucous Membrane Topical Solution — RxCUI 582808

RxNorm drug concept · Semantic clinical drug
RxCUI 582808 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI582808
Official nameCarbamide peroxide 100 MG/ML Mucous Membrane Topical Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ascarbamide peroxide 10 % Mucous Membrane Topical Solution
FDA products mapped1
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Carbamide peroxide 100 MG/ML Mucous Membrane Top... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Carbamide peroxide 100 MG/ML Mucous Membrane Topical Solution RxCUI 582808

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Carbamide peroxide 47686
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Gly-Oxide 1047876
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Carbamide peroxide Mucous Membrane Topical Solution 619237
    • Carbamide peroxide Mucosal Product 1158890
    • Carbamide peroxide Mucous Membrane Topical Solution [Gly-Oxide] 1048143
    • Gly-Oxide Mucosal Product 1171918
    • Mucous Membrane Topical Solution 316956
    • Mucosal Product 1151129
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Carbamide peroxide 100 MG/ML SCDC · 582806
  • Carbamide peroxide Mucous Membrane Topical Solution SCDF · 619237
  • Carbamide peroxide Mucosal Product SCDG · 1158890

Brand-Name Concepts

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 582808 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
63029-0500-01 1 BOTTLE in 1 CARTON (63029-500-01) / 15 mL in 1 BOTTLE Gly-Oxide Medtech Products Inc. 2012-06-01
63029-0500-02 1 BOTTLE in 1 CARTON (63029-500-02) / 60 mL in 1 BOTTLE Gly-Oxide Medtech Products Inc. 2012-06-01
Observed labelers: Medtech Products Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.